Obstructive sleep apnoea-hypopnoea (OSAH) syndrome constitutes a major health care problem. Surgical modalities for the treatment of OSAH are regaining momentum in view of the increasing prevalence of OSAH and the low compliance rates associated with continuous positive airway pressure. There are several investigations to complement clinical examination in accurately determining the level of airway collapse to ensure correct patient selection and a targeted surgical approach. The most commonly employed include drug-induced sleep endoscopy and imaging with the tongue base and epiglottis often revealed as the major sites of airway narrowing during sleep. In the continuing search for the optimal approach to address these areas, transoral robotic surgery (TORS) has been successfully used for tongue base reduction and epiglottoplasty. With sufficient experience, this technique is safe and well tolerated. Meticulous work-up and careful patient selection are crucial. Multiple studies have demonstrated very good short-term results of TORS for OSAH, with significant reduction in both the Apnoea-Hypopnea Index (AHI) and Epworth Sleepiness Score (ESS). With the appropriate infrastructure, proctoring, and access to robotic surgical technology, it is possible for these results to be reproduced more widely. Further prospective long-term clinical evaluation will ultimately determine the exact role of TORS in the treatment of OSAH.
Obstructive sleep apnoea-hypopnoea (OSAH) syndrome is a sleep disorder characterised by pauses in breathing (apnoea) or periods of reduced breathing (hypopnoea) during sleep resulting in intermittent cerebral hypoxia and a disturbed sleep pattern [1] . Depending on the frequency of these pauses, OSA is defined by an Apnoea-Hypopnoea Index (AHI) of greater than 5 h -1 and graded as mild (AHI: 5-15 h ), and severe (AHI >30 h -1 ) accordingly [2] . OSAH constitutes a major public health problem affecting over 10% of the world's population [3] . If untreated, it carries substantial morbidity and mortality primarily relating to cardiovascular and cerebrovascular events [4] . In addition, the presence of OSAH is associated with significant neurocognitive impairment and has been linked to both mental health problems and road traffic accidents [5] .
At present, the gold standard treatment for moderate to severe OSAH is the use of continuous positive airway pressure (CPAP). However, compliance rates with CPAP fall below 50% [1, 6] . As a result, various surgical procedures have been devised over the years to address the airway collapse depending on the anatomical level of obstruction [1] . Bariatric surgery also plays a major role in the treatment of OSAH as obesity represents a key driver for OSAH in the adult population [7] .
Transoral robotic surgery (TORS) represents the latest addition to the armamentarium of otorhinolaryngologists -head and neck surgeons for the treatment of OSAH [8] . Its superior visualisation and ergonomics make TORS an ideally suited minimally invasive surgical treatment for addressing all levels involved [8] .
Surgery of the Pharynx for OSAH and the Importance of Targeted Multilevel Treatment
In surgery of the upper airway for OSAH, the pharynx represents the primary target for treatment. It is important to appreciate that more often than not, OSAH is a multilevel disease with obstruction happening at more than one level [1] . The pharynx is a complex 3-dimensional structure comprising several structures: the hard palate, soft palate, and uvula superiorly, the tonsils, tonsillar fossae, and lateral oropharyngeal walls laterally, the posterior pharyngeal wall posteriorly, and the lingual tonsils, base of tongue, vallecula, and epiglottis inferiorly. Therefore, many different surgical procedures have been described to alter pharyngeal anatomy in an attempt to limit airway collapse during sleep. These can be arbitrarily categorised according to the specific working mechanism (resection, reinforcement, or transfer of tissue) (Fig. 1 ) or according to the airway level that is addressed (palate, tonsils, tongue base, and epiglottis).
As with all surgical procedures, careful patient selection is key to ensure optimal outcomes and promote patient safety [9, 10] . This should involve a systematic process involving a multidisciplinary team (including otorhinolaryngologists -head and neck surgeons, sleep physicians, and neurologists). History taking and clinical examination including fibreoptic pharyngolaryngoscopy, polysomnography, and drug-induced sleep endoscopy should form part of the standard assessment process along with other specialised investigations such as volumetric MRI depending on institutional expertise and availability [1, 11] . These will facilitate identifying all levels at which airway collapse occurs so that surgery can be targeted accordingly.
History of Tongue Base Surgery and the Introduction of Robotic Surgical Technology
Traditionally, surgery of the lower pharynx (tongue base and hypopharynx) has been challenging. There are various anatomical and physiological reasons for this including: (1) a narrow working space; (2) limited visualisation for the surgeon and the whole team; (3) a rich vascular supply from the lingual artery and collateral circulation from the facial artery; (4) absence of fixed anatomical landmarks; and (5) complex relationships to surrounding structures with important functions (e.g. breathing, protection of the airway, swallowing, and phonation) [12] .
Initial attempts to modify the tongue base for OSAH were through a transcervical suprahyoid approach [13] . However, an open approach to the tongue base proved difficult and was associated with significant morbidity making the procedure unpopular. As a result, minimally invasive transoral techniques were developed for tongue base hypertrophy including radiofrequency ablation and submucosal minimally invasive lingual excision. For radiofrequency ablation, the main criticism relates to the inaccuracy of the energy delivered and small effect on airway widening [14] . On the other hand, submucosal minimally invasive lingual excision achieves more accurate tissue resection, but the manipulation of tongue base tissues through the laryngoscope is often complicated by distortions of the architecture and bleeding [15] .
More recently, TORS has been introduced as a novel tool for accessing and resecting tissue from the tongue base and hypopharynx in a safe and more controlled manner [16] . The robotic advantages reported include improvements in visualisation (3-dimensional), magnification, and surgical precision facilitating the identification and preservation of critical vessels and nerves, haemostatic control, and precise tissue handling. These advantages enhance the surgeon's dissecting ability in such an anatomically and physiologically complex area and are partly responsible for the uptake of the technique.
State-of-the-Art TORS for OSAH Syndrome
The Royal College of Physicians (London, UK) in their most recent Clinical Update Sleep Consensus Statement (2018) includes a section on TORS describing it as a valid treatment option for multilevel OSAH in non-morbidly obese patients (BMI ≤35 kg/m 2 ) failing to tolerate CPAP [17] . However, due to the novelty of the procedure, there are no British, European or American guidelines for TORS in OSAH at present.
It is important to appreciate that TORS essentially represents a novel tool to perform conventional procedures to the oropharynx and hypopharynx. From this viewpoint, it can be argued that guidelines for conventional surgical procedures for the treatment of OSAH can be extended to TORS -though with adjustments relating to local expertise, infrastructure, and patient wishes. In this section, we present what we believe to be the state of the art for TORS in OSAH.
Patient Selection and Pre-Operative Work-Up
Patients should satisfy all of the following criteria for TORS to be considered as a treatment for OSAH: (1) moderate-to-severe OSA confirmed by polysomnography (defined as AHI ≥15 h -1 ), (2) failure to comply or refusal of all other treatment modalities including CPAP, and mandibular advancement device, (3) BMI < 35 kg/m 2 , and (4) predominant base of tongue collapse with or without epiglottic collapse evaluated by drug-induced sleep endoscopy [8, 18] .
A thorough work-up has to be carried out and should include history taking, use of validated patient-reported outcome measures (PROMs) such as the Epworth Sleeping Score (ESS), clinical examination, polysomnography, and drug-induced sleep endoscopy. During physical examination, special attention should be paid to mouth opening, dentition, Mallampati score, and biometric measures including neck circumference to ensure patient suitability for TORS and minimise the risk of subsequent exposure-related injuries (particularly to the teeth, lips, and temporomandibular joints) [19] . Fibreoptic pharyngolaryngoscopy must complement clinical examination to visualise the tongue base and perform the Mueller manoeuvre looking for retropalatal-hypopharyngeal collapse [1] . Imaging studies can also be performed for OSAH. When this is the case, MRI is the investigation of choice as this permits volumetric analysis before and after surgery [11] .
Finally, the surgeon must discuss the procedure in detail with the patient, including all alternative treatment options available, the number of cases personally performed and associated outcomes and complications, risks specific to TORS (including the risk of open conversion/cervicotomy to control potential haemorrhage, the need for a surgical tracheostomy and/or nasogastric tube insertion) [20] . The patient's wishes and concerns should be elicited and everything documented in detail in the electronic medical records for subsequent discussion in the institutional sleep medicine multidisciplinary team meeting [18] .
Anaesthetic Considerations in TORS
TORS requires specific anaesthetic considerations and close collaboration with a skilled anaesthetist and theatre team experienced in TORS. There are a number of reasons for this.
First, access to the endotracheal tube is significantly reduced during TORS, thus securing the connection pieces is vital. Second, the majority of OSAH patients, due to the nature of the disease, are likely to present with a difficult airway making endotracheal intubation challenging. This is further complicated by the fact that with TORS, nasotracheal intubation is preferable to maximise the space for the robotic arms in the oral cavity and optimise visualisation and access to the tongue base and epiglottis. Third, reinforced, laser-safe endotracheal tubes are recommended to minimise the risk of airway fire. However, such tubes are more rigid and wide and can thus be more traumatic particularly when the nasotracheal route is utilised for intubation. A topical vasoconstrictor to the nasal mucosa should be applied a few minutes prior to nasotracheal intubation. This is to minimise trauma and associated bleeding, which can in turn compromise visualisation during both intubation and surgery and even induce laryngospasm.
Unless there is a strong contraindication, the following medication should be administered intravenously at induction: a corticosteroid bolus (to reduce postoperative oedema), prophylactic antibiotics (especially if denuded epiglottic cartilage is anticipated), and proton pump inhibitors (to minimise the acidity of reflux gastric contents to the surgical wound postoperatively). The patient is positioned supine with the neck extended, and safety goggles, dental guards, and cheek retractors are placed, all subsequently covered with wet swabs for optimal patient safety (Fig. 2) .
The operating room configuration can be variable but it is important to arrange it in such a way so as to reduce the likelihood of disconnection of intravenous lines, monitoring device and robotic equipment cables, and ventilation tube extensions. The anaesthesia machine and anaesthetist are normally at the patient's foot.
TORS Operative Technique
As with all surgical procedures, exposure is key. The choice of retractor depends on patient anthropometrics, surgeon preference, and institutional availability. The most com- TORS is performed with the da Vinci ® surgical robotic system (Intuitive Surgical, Inc., Sunnyvale, CA, USA). The surgical robotic cart is positioned at 30° to the surgical bed on the right-hand side of the patient (Fig. 3) . Following trocar insertion, 3 robotic arms are used: one central 12 mm for the 0° (for palate) and 30° up (for tongue base and epiglottis) endoscope, and two 5 mm ones on either side for the instruments, the Maryland dissector forceps and Bovie monopoly diathermy (15J, blended mode).
Tongue base reduction is commenced with an initial horizontal cut just posterior to the distal end of the tongue blade. This should be just behind the foramen caecum and circumvallate papillae and should extend laterally to the vallecula (Fig. 4a) . This incision creates an edge that can be grasped with the Maryland dissector forceps and then deepened broadly. The lingual tonsils are separately resected on either side with a division in the midline. All lingual tonsillar tissue is resected down to the muscle. A portion of the muscle can also be removed from the midline to further reduce the tongue base. A less aggressive alternative to resection is tongue base ablation with the thulium laser (273 μm, 15 W), which can also be mounted on to one of the robotic arms [18] . The lateral limits should extend to 1 cm laterally (to protect the neurovascular bundle on either side) and 2 cm in terms of depth. Irrespective of which technique is used, care should be taken with the tributaries of the dorsal lingual artery and the lingual vein. These can be either cauterised or clipped. Depending on the levels of airway collapse identified preoperatively, tongue base reduction can be followed by epiglottoplasty (Fig. 4b) . The upper third of the suprahyoid epiglottis can be removed (Fig. 5) . The epiglottis is held with the Maryland dissector, and the superior part is removed with the Bovie electrocautery. The level of epiglottic resection should stop at above the pharyngoepiglottic folds to minimise the chances of aspiration and also prevent bleeding from inadvertent injury to branches of the superior laryngeal artery. The volume of tissue removed is measured at the end of the procedure and documented in the operative record (Fig. 6) .
If multiple levels are being addressed and/or access is proving more challenging than initially anticipated resulting in prolonged operative time, it is important to stop every 30-45 min and release the mouth gag for a minimum of 10 min. This will re-establish venous and lymphatic outflow and reduce the chance of postoperative oedema that can in turn lead to airway obstruction and the need for emergency tracheostomy. Moreover, releasing the pressure from the tongue blade at regular time intervals will reduce the chances of lingual and hypoglossal nerve neurapraxia, an underreported complication following TORS.
Postoperative Care
Patients are extubated at the end of the procedure, and at this point careful attention should be paid to the airway status. Postoperative corticosteroids and regular analgesia including opioids should be prescribed to minimise swelling, nausea, and pain. Patients should be admitted to the surgical intensive care unit for airway monitoring for the first postoperative night. Early speech and language therapy is very important to encourage swallowing and expedite the re-establishment of a normal diet. Patients are usually discharged within 24-48 h after surgery once they have been commenced on a soft diet and their pain is controlled. Nasogastric tube insertion and tracheostomy are not routinely required. Patients are seen in the outpatient clinic initially 2 weeks after their surgery and at regular time intervals thereafter to monitor the long-term effects of TORS on the severity of OSAH (Fig. 7) .
The Evidence Base for TORS as a Treatment for OSAH Syndrome

Outcomes of Single Level TORS for OSAH Syndrome
As most of the studies on robotic tongue base surgery report on multilevel surgery outcomes, it is difficult to comment on outcomes for single level TORS for OSAH syndrome.
Lin et al. [21] , in the only retrospective study (n = 12) to look at TORS base of tongue resection alone, demonstrated a significant mean postoperative reduction in AHI and ESS from 43.9 (41.1) to 17.6 (16.2) (p = 0.007) and from 13.7 (5.2) to 6.4 (4.5) (p < 0.001), respectively. However, the majority of patients in this small study had previously undergone other types of upper airway procedures, including uvulopalatopharyngoplasty, coblation-assisted lingual tonsillectomy, hyoid advancement, and tracheostomy. In a large multicentre study by Vicini et al. (n = 243) [22] , TORS was selected as a standalone procedure in only 14% of cases. No comparison was made between robotic tongue base reduction alone and robotic tongue base reduction combined with other procedures.
Outcomes of Multilevel TORS for OSAH Syndrome
Almost all studies on TORS for OSAH involve robotic procedures in combination with non-robotic surgical sleep procedures. This heterogeneity makes it difficult to evaluate the true effectiveness of robotic surgery in isolation [8] . Moreover, the majority of studies is limited in terms of both patient numbers and/or follow-up time and commonly includes cases performed at the beginning of surgeons' learning curves.
Taking into account these limitations, a best evidence topic by Garas et al. [8] in 2017 reviewing the most up-to-date evidence on the subject showed that TORS has been consistently reported to be effective in over 75% of non-obese OSAH patients and over 50% of nonmorbidly obese OSAH patients (BMI = 30-35 kg/m 2 ) though they also pointed out the absence of randomised controlled trials to support these findings. Following this, TORS was included by the Royal College of Physicians (London, UK) in their most recent Clinical Update Sleep Consensus Statement (2018) as a valid treatment option for multilevel OSAH in non-morbidly obese patients (BMI ≤35 kg/m 2 ) failing to tolerate CPAP [17] . A meta-analysis by Justin et al. in 2015 [23] pooled the outcomes of 16 studies concerning TORS for OSAH syndrome. The results were encouraging, with a statistically significant reduction in both AHI and ESS and an associated increase in mean oxygen saturation levels postoperatively. However, it is important to reiterate that TORS was almost always combined with other non-robotic sleep surgery procedures and that there were no randomised studies included (there are none at present) with most studies being retrospective (only 2 studies were prospective). Although the absence of randomised controlled trials is a common occurrence in surgical research [24] , it calls for caution when trying to derive any conclusions about the value of robotic surgery in OSAH syndrome based on existing study findings [25] . Some articles looked at predictive factors for surgical success with BMI ≤30 kg/m 2 [26, 27] , AHI ≤60 h -1 [27] , absence of lateral pharyngeal wall collapse [27] , and amount of tissue resected between 10 and 20 mm 3 reported to be the most clinically relevant predictors [28] . In terms of subgroup analysis, the existing evidence supports the effectiveness of TORS in over 75% of non-obese OSAH patients (subject to correct patient selection) with success rates dropping steeply with increasing BMI [8] .
Safety of TORS for OSAH Syndrome
An average complication rate of 22.3% in TORS for OSAH syndrome is reported in the literature [23] . This rate is comparable to previous studies evaluating non-robotic surgical operations for OSAH including lingualplasty, radiofrequency ablation, uvulopalatopharyngoplasty, maxillomandibular advancement, and midline glossectomy [29] .
Common complications associated with TORS for OSAH syndrome and their incidence (where reported) are presented in Table 1 .
The most common complications of TORS are the same as those with conventional transoral surgery either with the Bovie or transoral laser microsurgery (TLM). These primarily relate to postoperative pain, swallowing problems, and haemorrhage. As mentioned earlier, prolonged surgery without the intermittent release of the mouth gag can lead to venous obstruction and lymphoedema of the tongue that can in turn lead to airway obstruction and the need for an emergency tracheostomy. Direct pressure from the tongue blade can also result in lingual and hypoglossal nerve neurapraxia. These constitute important -and avoidable -complications, often underreported in the literature.
Establishing and Running a Robotic Programme for OSAH Syndrome
Robotic surgery is an innovative and complex technology that requires substantial commitment on behalf of the surgeon and his/her team to ensure its safe implementation. Safe adoption combined with methodical analysis of results will ultimately determine the success or failure of this surgical technology [25] . The infrastructure, learning curve, setting and financial context have to be right to be able to establish and run a robotic programme for OSAH.
Infrastructure TORS is currently being used for sleep disordered breathing in a limited number of centres around the world [8] . The primary reason relates to the availability of the robot and associated equipment in the home institution, which in turn are directly related to the purchasing, maintenance, and consumable costs. But other conditions have to be fulfilled too. The surgeon has to obtain approval by their institution and all stakeholders and ensure the full support from their department. Careful observation should be made that the existing practice has a sufficient target population to build up experience with the procedure. A dedicated theatre team should be identified and trained. Operating room personnel should be included in the educational process and should have experience with other types of endoscopic head and neck surgery. Efforts should be made to ensure consistency of participating personnel.
Experience and Learning Curve
Adapting a new operative technique and technology means implementing a series of necessary steps: (1) robotic skill acquisition: all team members should review educational materials and complete simulation training to become familiar with the robot mechanisms; (2) case observations and mentoring [30] : key members of the group should learn the procedure from a surgical team with extensive experience in addition to self-studying surgical videos of the technique; (3) animal and cadaver dissections [19] ; (4) planning: individual responsibility should be assigned to each team member and strategies planned in the event of a potential system failure; (5) proctored cases: the initial cases should be proctored by an experienced TORS surgeon; and (6) data collection for the purposes of audit.
This implementation phase can be labour-intensive and time-consuming. Therefore, any other experience with the robot for other indications can help to shorten this learning curve.
Multidisciplinary Setting
TORS should be performed in centres where there is a specific multidisciplinary programme for OSAH syndrome. Patient evaluation and selection should be in collaboration with colleagues from respiratory and sleep medicine, and neurology. The robotic sleep surgeon must be knowledgeable about all types of management for sleep disordered breathing and have easy access to the other members of the multidisciplinary team particularly in terms of referring patients. In the future, efforts should be made to establish multidisciplinary guidelines for patient selection in TORS for OSAH.
Financial Context
Robotic surgery is costly resulting in its value often being questioned [25, 34] . Considerations should be made regarding the cost-effectiveness for the patient and the institution. However, this can vary depending on the national health care system of each country and even within the same country, depending on whether TORS for OSAH syndrome is offered in the public or private health care setting. 
Future Developments
At present, the major limitation of robotic surgical systems is their prohibitive cost [25, 34] . This is likely to change in the near future as patents expire and newer robotic systems emerge creating market competition and driving down costs.
The Flex ® System (Medrobotics ® Inc., Raynham, MA, USA) represents the more recently introduced surgical robot specifically designed for TORS [35] . This consists of an operatorcontrolled computer-assisted flexible endoscope with articulated segments. Once positioned, the scope can become rigid, forming a stable surgical platform from which the surgeon can insert flexible surgical instruments. The Flex ® System has obtained clearance both in the EU (CE mark 2014) and the USA (FDA clearance 2015) [36] .
Other robotic systems include the ones developed by Medtronic, Inc. Increasing competition is not only likely to make robotic surgical technology (including TORS) cheaper and thus more widely affordable but to also expand its applications and indications through continuous technological advances. For OSAH, this may mean novel, miniaturised, and flexible robots that will permit addressing levels not accessible with the existing robotic technology. An example includes accessing the nasopharynx endoscopically without the need of compromising the integrity of the soft palate, a technique currently being experimented on cadaveric models [37] .
Conclusion
Surgical modalities for the treatment of OSAH are regaining momentum in view of the increasing prevalence of OSAH and the low compliance rates associated with CPAP. Through its enhanced ergonomics and visualisation, TORS overcomes the difficulties of accessing the tongue base and hypopharynx, thus rendering it ideal for multilevel targeted surgery. Though still a novel treatment for OSAH, early results are promising provided careful patient selection is employed. The development and introduction of new robotic systems is likely to not only drive down costs through market competition making TORS more widely affordable but to also accelerate robotic technological advances. This may translate to novel, miniaturised, and flexible robots that will permit addressing levels not accessible with the existing robotic surgical technology thus further expanding its indications. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors declare no conflicts of any commercial interest.
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